BSE Live
Feb 10, 16:01Prev. Close
1290.00
Open Price
1300.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Feb 10, 15:42Prev. Close
1299.70
Open Price
1329.90
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Cash Flow of HALEOS LABS (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 30.04 | 19.11 | 16.02 | 20.28 | 19.35 | |
| Net CashFlow From Operating Activities | 28.03 | 14.75 | 4.58 | -14.66 | 21.62 | |
| Net Cash Used In Investing Activities | -13.77 | -13.75 | -27.96 | -7.49 | -5.94 | |
| Net Cash Used From Financing Activities | -14.20 | -0.82 | 22.59 | 14.63 | -7.87 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 0.07 | 0.18 | -0.80 | -7.52 | 7.81 | |
| Cash And Cash Equivalents Begin of Year | 0.33 | 0.15 | 0.95 | 8.46 | 0.65 | |
| Cash And Cash Equivalents End Of Year | 0.40 | 0.33 | 0.15 | 0.95 | 8.46 |
17.11.2025
SMS Lifescience Consolidated September 2025 Net Sales at Rs 81.37 crore, up 3.7% Y-o-Y
12.11.2025
SMS Lifescience Standalone September 2025 Net Sales at Rs 77.84 crore, down 0.83% Y-o-Y
08.09.2025
SMS Lifescience Standalone June 2025 Net Sales at Rs 79.04 crore, down 8.7% Y-o-Y
12.06.2025
SMS Lifescience Standalone March 2025 Net Sales at Rs 85.43 crore, down 1.1% Y-o-Y
15.02.2017
15.02.2017
14.02.2017
13.02.2017